Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.18B
Enterprise Value5.91B
P/E Ratio60.11
PEG Ratio2.7
Price/Sales Ratio6.68
Price/Book Ratio3.2
Enterprise/Revenue6.28
Enterprise/EBITDA44.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.11
Operating Margin0.1
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.05

Income Statement

Revenue827.14M
Revenue/Share2.02
Gross Profit474.67M
EBITDA165.69M
Net Income65.09M
Diluted EPS0.16

Balance Sheet

Total Cash584.31M
Total Cash/Share1.4
Total Debt2.16M
Total Debt/Equity0
Current Ratio5.38
Book Value Per Share4.23

Price History

52-Week Change-18.72
52-Week High18.47
52-Week Low11.42
Moving Average 50 Days14.15
Moving Average 200 Days13.89

Statistics

Average Volume14.75M
Shares Outstanding417.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield0.56
Payout Ratio0.16
Last Split FactorN/A
Last Split DateN/A
AD